Director received an award of 180.32 ZBH derivative securities | OQRO Insider tradesWhy it stands out
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Jun 30, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Jul 2, 2026
DirectorGrant / award
Context
- Classification
grant award
Code A — grant or award
- Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001910621-26-000008
- Filed / recorded
Added to OQROOct 2, 2026, 12:29 PM UTC Data qualityVerified: identifiers matched exactly IssuerZIMMER BIOMET HOLDINGS, INC. Reporting personDevdatt Kurdikar SecurityPhantom Stock Units TableDerivative (Table II) Transaction dateJun 30, 2026 Acquired / disposedAcquired (A) Shares owned after2,990.182 Footnotes from the filing
- The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
- The Conversion or Exercise Price of Derivative Security is 1-for-1.
- Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
Around the same time
Congress tradeSits on Senate Health, Education, Labor, and Pensions Disclosed 116 days after the transaction; reported as an official range, not an exact amount.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.